Search

everythinglearnresearchcommunity

for

Search:↓

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

Occipital scalp affects female hair loss; terminal/vellus ratio helps diagnose androgenetic alopecia.

Combining growth factors with minoxidil improves hair growth more than minoxidil alone.

Trichoscopy is effective for tracking treatment progress in hair loss when used by an experienced doctor.

Hair density and thickness decrease in specific scalp areas in people with androgenetic alopecia.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Horizontally sectioned scalp biopsies are more reliable for diagnosing hair loss in women when three samples are taken instead of one.

The boy with woolly hair nevus had thinner hair and abnormal hair follicles, which improved with treatment but worsened when treatment stopped.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Intense Pulsed Light is an effective and safe hair removal method for people with excessive hair growth.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

The study found average numbers for different types of hair follicles in the scalp and observed differences between men and women, suggesting reasons for more common hair shedding in women.

Southern Chinese women with female pattern hair loss have less, thinner hair and smaller hair follicles.

Alopecia common in teens, may indicate endocrine issue, minoxidil effective treatment.

The modified hair loss classification is more detailed but less user-friendly.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.

CGF from platelets helps hair regrowth in people with androgenetic alopecia.

CGF injections may safely and effectively promote hair growth in androgenetic alopecia patients.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Combining platelet-rich plasma, microneedling, and minoxidil improves hair growth.

Trichoscopy effectively diagnoses early female hair loss, but may need scalp biopsy for confirmation.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Minoxidil and spironolactone combo effectively treats androgenetic alopecia, improving hair density and diameter.

Intense pulsed light treatment effectively reduces underarm hair by making hair follicles smaller and extending their resting phase.

Injections improve hair growth, density, and thickness in women safely.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

Different scalp imaging methods are important for studying hair and scalp health and require more volunteers for better evaluation.